Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Stericycle Inc    SRCL

Delayed Quote. Delayed  - 08/29 10:00:00 pm
84.68 USD   +1.23%
08/29 SRCL The Law Offices of Vincent Wong Notifies Investors of a Clas..
08/19 SRCL The Law Offices of Vincent Wong Notifies Investors of a Comm..
08/16 STERICYCLE : Lawsuit for Investors in shares of Stericycle Inc annou..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Sales2 1432 5562 9863 5703 7323 930
Operating income (EBITDA)6457207899351 0001 114
Operating profit (EBIT)556615662713795887
Pre-Tax Profit (EBT)478-----
Net income311326255285390463
P/E ratio32,634,640,726,019,017,1
EPS ( $ )3,563,792,963,254,464,97
Dividend per Share ( $ )---0,22--
Yield---0,26%--
Reference price ( $ )116.17131.08120.684.6884.6884.68
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201320142015201620172018
Debt1 3691 6373 1581 1472 5792 151
Finance------
Operating income (EBITDA)6457207899351 0001 114
Leverage
(Debt/EBITDA)
2,12x2,27x4,00x1,23x2,58x1,93x
Capital Expenditure73,186,5115131134133
Book Value Per Share (BVPS)20,6 $22,4 $32,1 $33,2 $37,4 $43,6 $
Cash Flow per Share4,62 $5,20 $4,53 $5,13 $5,68 $6,30 $
Announcement Date02/05/2014
09:02pm
02/05/2015
09:02pm
02/04/2016
09:02pm
---
Balance Sheet Analysis
Assessed data source :
© 2016 Thomson Reuters
Advertisement
Financial Ratios

Size 2016e 2017e
Capitalization 7 201 M$ -
Entreprise Value (EV) 8 348 M$ 9 780 M$
Valuation 2016e 2017e
P/E ratio (Price / EPS) 26,0x 19,0x
Capitalization / Revenue 2,02x 1,93x
EV / Revenue 2,34x 2,62x
EV / EBITDA 8,92x 9,78x
Yield (DPS / Price) 0,26% -
Price to book (Price / BVPS) 2,55x 2,27x
Profitability 2016e 2017e
Operating Margin (EBIT / Sales) 20,0% 21,3%
operating Leverage (Delta EBIT / Delta Sales) 0,40x 2,53x
Net Margin (Net Profit / Revenue) 7,99% 10,4%
ROA (Net Profit / Asset) 25,3% 7,88%
ROE (Net Profit / Equities) 12,9% 11,7%
Rate of Dividend 6,76% -
Balance Sheet Analysis 2016e 2017e
CAPEX / Sales   3,67% 3,58%
Cash Flow / Sales 12,2% 12,9%
Capital Intensity (Assets / Sales) 0,32x 1,32x
Financial Leverage (Net Debt / EBITDA) 1,23x 2,58x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend